HealthQuill Lung CAncer
Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients with metastatic uveal melanoma, giving the Delaware-based firm $60 million fund access.
Drugs Health Pharma

Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma

HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.

Read More
AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.
Drugs Health Medical Pharma

AstraZeneca’s drug cuts risk of lung cancer death by 51%, trials show

HQ Team June 5, 2023: AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the.

Read More